NASDAQ | TSX: ACB
EDMONTON, AB, Aug. 29,
2022 /PRNewswire/ - Aurora Cannabis Inc. (the
"Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian
company defining the future of cannabinoids worldwide, announced
today that it has scheduled a conference call to discuss the
results for its fourth quarter and full fiscal year 2022 on
Tuesday, September 20, 2022 at
5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report
its financial results for the fourth quarter and full fiscal year
2022 after the close of markets that same day.
Conference Call Details
DATE:
|
Tuesday, September 20,
2022
|
TIME:
|
5:00 p.m. Eastern Time
| 3:00 p.m. Mountain Time
|
WEBCAST:
|
Click here
|
Miguel Martin, Chief Executive
Officer, and Glen Ibbott, Chief
Financial Officer, will host the conference call and question and
answer period. This weblink has also been posted to the Company's
"Investor Info" link at https://investor.auroramj.com/ under "News
& Events".
Additionally, Aurora has announced that along with the filing of
its annual financial statements, it expects to file other annual
disclosure documents – including the Annual Information Form.
Furthermore, Aurora announced that it has scheduled its Annual
General and Special Meeting of shareholders, which will be held
virtually on Monday, November 14,
2022 at 1 p.m. Eastern Time |
11:00 a.m. Mountain Time. In
conjunction with the meeting, Aurora expects to file its
Information Circular and related proxy materials, which will be
available for download under its profile on both SEDAR and
EDGAR.
About Aurora
Aurora is a global leader in the cannabis industry, serving both
the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in
global cannabis, dedicated to helping people improve their lives.
The Company's adult-use brand portfolio includes Aurora Drift, San
Rafael '71, Daily Special, Whistler, Being and Greybeard, as
well as CBD brands, Reliva and KG7. Medical
cannabis brands include MedReleaf, CanniMed, Aurora and
Whistler Medical Marijuana Co. Aurora also has a controlling
interest in Bevo Farms, North
America's leading supplier of propagated agricultural
plants. Driven by science and innovation, and with a focus on
high-quality cannabis products, Aurora's brands continue to break
through as industry leaders in the medical, performance, wellness
and adult recreational markets wherever they are launched. Learn
more at www.auroramj.com and follow us on Twitter and
LinkedIn.
Aurora's common shares trade on the NASDAQ and TSX under the
symbol "ACB" and is a constituent of the S&P/TSX Composite
Index.
Forward Looking
Statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. Forward-looking statements made in this news
release include statements regarding timing of the release of the
Company's financial statements for fourth quarter ended June
30, 2022 and associated conference call, as well as timing for
our Annual General and Special Meeting and filing of related proxy
materials.
These forward-looking statements are only predictions. Forward
looking information or statements contained in this news release
have been developed based on assumptions managements considers to
be reasonable. Material factors or assumptions involved in
developing forward-looking statements include, without limitation,
publicly available information from governmental sources as well as
from market research and industry analysis and on assumptions based
on data and knowledge of this industry which the Company believes
to be reasonable. Forward-looking statements are subject to a
variety of risks, uncertainties and other factors that management
believes to be relevant and reasonable in the circumstances could
cause actual events, results, level of activity, performance,
prospects, opportunities or achievements to differ materially from
those projected in the forward-looking statements. These risks
include, but are not limited to, the ability to retain key
personnel, the ability to continue investing in infrastructure to
support growth, the ability to obtain financing on acceptable
terms, the continued quality of our products, customer experience
and retention, the development of third party government and
non-government consumer sales channels, management's
estimates of consumer demand in Canada and in
jurisdictions where the Company exports, expectations of future
results and expenses, the risk of successful integration of
acquired business and operations, management's estimation that
SG&A will grow only in proportion of revenue growth, the
ability to expand and maintain distribution capabilities, the
impact of competition, the general impact of financial market
conditions, the yield from cannabis growing operations, product
demand, changes in prices of required commodities, competition, and
the possibility for changes in laws, rules, and regulations in the
industry, epidemics, pandemics or other public health crises,
including the current outbreak of COVID-19, and other risks,
uncertainties and factors set out under the heading "Risk Factors"
in the Company's annual information form dated September 27,
2021 (the "AIF") and filed with Canadian securities regulators
available on the Company's issuer profile on SEDAR
at www.sedar.com and filed with and available on the
SEC's website at www.sec.gov. The Company cautions that the
list of risks, uncertainties and other factors described in the AIF
is not exhaustive and other factors could also adversely affect its
results. Readers are urged to consider the risks, uncertainties and
assumptions carefully in evaluating the forward-looking statements
and are cautioned not to place undue reliance on such information.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable securities
law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aurora-cannabis-to-host-fourth-quarter-and-full-fiscal-year-2022-investor-conference-call-and-related-year-end-informational-filings-301614031.html
SOURCE Aurora Cannabis Inc.